Topics

Humana Works to Increase Capacity for Coronavirus Treatment

10:15 EDT 26 Mar 2020 | Businesswire
Humana Inc.

To prepare for the influx of patients who will need to be treated for coronavirus (COVID-19), Humana Inc. (NYSE: HUM) is taking steps to make it easier for members and health systems. Specifically, the national health company is lifting administrative requirements for the care of all members infected with coronavirus and for all patients in settings where capacity is stretched by the needs of those infected by coronavirus allowing for unencumbered movement from inpatient hospitals to safe, medically appropriate post-acute care settings, including home health, long-term acute care hospitals, skilled nursing facilities, etc.

Humana is asking its providers to notify them of the transitions by the following business day in order to continue care coordination for its members. Providers may visit https://www.humana.com/provider/coronavirus for more information.

“Humana is working in partnership with leaders across the health care industry to ensure the system works efficiently and effectively for our country, especially as we face an onslaught of people in need of care,” said Bruce Broussard, Humana president and CEO. “It’s a fast changing environment and one in which we are committed to doing our part to remove friction to make it easier for clinicians to assist our members in getting the care they need.”

Care transitions are being facilitated for both patients being treated for COVID-19 and for all patients hospitalized in settings of COVID-related limits on health system capacity. By moving patients from hospitals to other care facilities, Humana hopes to support hospital capacity for COVID-19 treatment, especially in the locations where health care services are already strained.

In addition, Humana is continuing to provide the following resources to its members:

  • waiving member cost share for all telehealth services delivered by participating/in-network providers and accepting audio-only telephone visits for reimbursement;
  • waiving the out-of-pocket costs (copays, coinsurance and deductibles) associated with COVID-19 testing, including related visit costs in a range of clinical settings such as a physician’s office, urgent care center or emergency department;
  • allowing early prescription refills, so members can prepare for extended supply needs – an extra 30- or 90-day supply as appropriate;
  • and providing a member support line with specially trained call center employees to help support members with specific coronavirus questions and concerns, including live assistance with telehealth.

About Humana

Humana Inc. is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience with the goal of making health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s website at humana.com, including copies of:

  • Annual reports to stockholders
  • Securities and Exchange Commission filings
  • Most recent investor conference presentations
  • Quarterly earnings news releases and conference calls
  • Calendar of events
  • Corporate Governance information.

 

Kate Marx
Humana Corporate Communications
502-271-9288
Kmarx1@humana.com

NEXT ARTICLE

More From BioPortfolio on "Humana Works to Increase Capacity for Coronavirus Treatment"

Quick Search

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...